Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors-Reference-Cited by-同舟云学术

Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors

Published:2002-09-26 Issue:1 Volume:102 Page:86-90
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Karamouzis Michalis V.,Likaki-Karatza Eleni,Ravazoula Panagiota,Badra Filitsa A.,Koukouras Dimitrios,Tzorakoleftherakis Evagelos,Papavassiliou Athanasios G.,Kalofonos Haralambos P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Screening Sensitivity and Sojourn Time From Breast Cancer Early Detection Clinical Trials: Mammograms and Physical Examinations

2. Mammographic screening: no reliable supporting evidence?

3. Breast Microcalcifications: Multivariate Analysis of Radiologicand Clinical Factors for Carcinoma

4. Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?

5. Histopathological and Cell Biological Factors of Ductal Carcinoma in Situ Before and After the Introduction of Mammographic Screening

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological characteristics and prognostic significance of casting-type calcifications in patients with invasive breast cancer presenting with microcalcification;Scientific Reports;2024-06-10

2. Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer;Cancer Letters;2024-04

3. YAP/TAZ‐TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma;Journal of Cellular and Molecular Medicine;2024-04

4. Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients;BMC Women's Health;2024-03-20

5. Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer;Mini-Reviews in Medicinal Chemistry;2024-03